CTSG and rheumatoid arthritis: As mentioned earlier, the diseases that may benefit from CatG inhibitors include rheumatoid arthritis, ischaemic reperfusion injury, coronary artery disease, acute respiratory distress syndrome, chronic obstructive pulmonary disease and cystic fibrosis.